PAI-1 4G/5G Mutation Detection Kit
£326.00
The Plasminogen Activator Inhibitor 1 (PAI-1/SERPINE1) 4G/5G Mutation Detection Kit is tailored for the identification of the 4G allele in the PAI-1 gene, a mild risk factor for venous thromboembolism (VTE) and Myocardial Infarction (MI). Utilizing multiplex RT-PCR technology, this kit simplifies the detection process of this specific genetic variation, contributing to a comprehensive assessment of thrombophilia risk.
The Plasminogen Activator Inhibitor 1 (PAI-1/SERPINE1) 4G/5G Mutation Detection Kit is tailored for the identification of the 4G allele in the PAI-1 gene, a mild risk factor for venous thromboembolism (VTE) and Myocardial Infarction (MI). Utilizing multiplex RT-PCR technology, this kit simplifies the detection process of this specific genetic variation, contributing to a comprehensive assessment of thrombophilia risk.
- Ready to Reaction Mix: Minimizes preparation time, enhancing ease of use for laboratory staff.
- Accurate Results: Includes controls for both homozygous and heterozygous mutations to ensure the reliability of test outcomes.
- Dual Color Compatibility: Compatible with real-time PCR instruments that detect FAM and VIC/HEX, enabling simultaneous detection of multiple genetic markers.
- CE-IVD Certification: Adheres to European standards for in vitro diagnostic medical devices, ensuring the kit’s quality and dependability.
- Simplified Testing Procedure: The kit’s pre-prepared reaction mix streamlines the testing process, allowing for rapid and efficient detection.
- Dependable Diagnostics: By including specific controls, the kit offers accurate results critical for genetic risk assessment.
- Versatile Instrument Compatibility: Designed for use with a wide array of dual-color real-time PCR instruments, increasing its usability.
- Certified Quality: The CE-IVD mark confirms that the kit complies with EU regulations, providing a high standard of diagnostic performance.
Genetic Risk Assessment for Thrombophilia and Cardiovascular Diseases: Primarily aimed at detecting the PAI-1 4G/5G polymorphism, this kit serves as an important tool for evaluating genetic predispositions to thrombophilia, VTE, and myocardial infarction.
- Technology: Employs multiplex RT-PCR for the targeted detection of the PAI-1 4G/5G polymorphism, among other genetic risk factors for thrombophilia.
- Compatibility: Suitable for FAM and VIC/HEX dual-color real-time PCR instruments.
- Controls Included: Features controls for both homozygous and heterozygous conditions to validate assay accuracy.
- Certification: Carries the CE-IVD marking, indicating its suitability for in vitro diagnostic use within the European Union.
Why Choose Clent
We strive to enable our customers to focus on the results of their work, rather than the tools they use. Need to speak with a member of our team? Get in touch today.
